tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Denys-Drash Syndrome D030321 1 associated lipids
Hypophosphatemia D017674 1 associated lipids
Moyamoya Disease D009072 1 associated lipids
Latent Tuberculosis D055985 1 associated lipids
Leukoplakia D007971 1 associated lipids
Oculomotor Nerve Diseases D015840 1 associated lipids
Scorpion Stings D065008 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Mediastinitis D008480 2 associated lipids
Coproporphyria, Hereditary D046349 1 associated lipids
Ileus D045823 3 associated lipids
Rectal Diseases D012002 1 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Zhang CW et al. [Establishment of a real-time PCR assay for simultaneously detecting human BKV and CMV DNA and its application in renal transplantation recipients]. 2013 Bing Du Xue Bao pmid:23895006
Gray FL et al. Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis. 2013 J. Pediatr. Surg. pmid:23895969
Foroncewicz B et al. A comparison between two tacrolimus-based immunosuppression regimens in renal transplant recipients: 7-year follow-up. 2013 Ann. Transplant. pmid:23896824
Armenti VT et al. Breastfeeding and tacrolimus: is it a reasonable approach? 2013 Expert Rev Clin Immunol pmid:23899232
Danby SG and Cork MJ The effects of pimecrolimus on the innate immune response in atopic dermatitis. 2013 Br. J. Dermatol. pmid:23362967
Gómez-Bravo MA et al. Impact of donor and recipient CYP3A5 and ABCB1 genetic polymorphisms on tacrolimus dosage requirements and rejection in Caucasian Spanish liver transplant patients. 2013 J Clin Pharmacol pmid:23900887
Yoon SH et al. CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III). 2013 Transplantation pmid:23364483
Nakatani K [Personalized medicine in transplantation therapy]. 2013 Rinsho Byori pmid:23947183
Yu JJ et al. Inhibition of calcineurin in the prefrontal cortex induced depressive-like behavior through mTOR signaling pathway. 2013 Psychopharmacology (Berl.) pmid:22875481
Rosado-Rubio C et al. Delayed introduction of tacrolimus in sub-optimal kidneys. A short-term follow-up study in the University Hospital of Salamanca. 2013 Nefrologia pmid:23364645
Spriet I et al. Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction. 2013 Eur. J. Clin. Pharmacol. pmid:22878691
Neto P et al. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report. 2013 Nefrologia pmid:23364650
Rabie R et al. Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-analysis. 2013 Liver Transpl. pmid:22821730
Yuda S et al. [Sodium-losing nephropathy caused by tacrolimus after allogeneic hematopoietic stem cell transplantation]. 2013 Rinsho Ketsueki pmid:24452151
Nobuoka Y et al. Immune response following liver transplantation compared to kidney transplantation: usefulness of monitoring peripheral blood CD4+ adenosine triphosphate activity and cytochrome P450 3A5 genotype assay. 2013 Clin. Dev. Immunol. pmid:24454479
Nanaeva BA and Vardanian AV [Tacrolimus in perianal manifestations of Crohn's disease]. 2013 Eksp Klin Gastroenterol pmid:24294772
Okamoto M et al. Successful treatment with tacrolimus in a case of lung-dominant connective tissue disease. 2013 Intern. Med. pmid:23448773
Muili KA et al. Bile acids induce pancreatic acinar cell injury and pancreatitis by activating calcineurin. 2013 J. Biol. Chem. pmid:23148215
Brzezińska B et al. Factors associated with glucose metabolism disorders after kidney transplantation. 2013 Endokrynol Pol pmid:23450443
Akelma AZ et al. A diagnostic dilemma: inflammatory linear verrucous epidermal nevus versus linear psoriasis. 2013 J. Pediatr. pmid:23149170
Lemaitre F et al. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients. 2013 Clin. Biochem. pmid:23454394
Park JH et al. The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration. 2013 Photodermatol Photoimmunol Photomed pmid:23458396
Zuo XC et al. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis. 2013 Pharmacogenet. Genomics pmid:23459029
Boivin AA et al. Influence of SLCO1B3 genetic variations on tacrolimus pharmacokinetics in renal transplant recipients. 2013 Drug Metab. Pharmacokinet. pmid:23149872
van den Hoogen MW et al. Effect of a single intraoperative high-dose ATG-Fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: a randomized study. 2013 Exp Clin Transplant pmid:23431996
Brown RS et al. Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case report. 2013 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:23102802
van den Hoogen MW et al. Insulin requirement after a renal transplant in patients with type 2 diabetes: the choice of calcineurin inhibitors. 2013 Exp Clin Transplant pmid:23432070
Matsuoka K and Hibi T Treatment guidelines in inflammatory bowel disease: the Japanese perspectives. 2013 Dig Dis pmid:24246989
Palacín M et al. FK506 affects mitochondrial protein synthesis and oxygen consumption in human cells. 2013 Cell Biol. Toxicol. pmid:24077807
Hu AB et al. Safety and efficacy of four steroid-minimization protocols in liver transplant recipients: 3-year follow-up in a single center. 2013 J Dig Dis pmid:23134408
Verma S et al. Preradial myxedema in a euthyroid male: A distinct rarity. 2013 Dermatol. Online J. pmid:24021369
Yosipovitch G et al. A comparative study of clinical characteristics, work-up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore. 2013 Int. J. Dermatol. pmid:22835263
Hirsch HH et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. 2013 Am. J. Transplant. pmid:23137180
Uchino M et al. Topical tacrolimus therapy for antibiotic-refractory pouchitis. 2013 Dis. Colon Rectum pmid:24022534
Durand P et al. Tacrolimus dose requirement in pediatric liver transplantation: influence of CYP3A5 gene polymorphism. 2013 Pharmacogenomics pmid:23837476
Lamoth F et al. In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains. 2013 Antimicrob. Agents Chemother. pmid:23165466
de Jonge H et al. Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism. 2013 Pharmacogenomics pmid:24024898
Gijsen VM et al. CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients. 2013 Pharmacogenomics pmid:23837477
Zhu Q et al. Pluronic F127-modified liposome-containing tacrolimus-cyclodextrin inclusion complexes: improved solubility, cellular uptake and intestinal penetration. 2013 J. Pharm. Pharmacol. pmid:23837579
Shihab FS et al. Effect of corticosteroid withdrawal on tacrolimus and mycophenolate mofetil exposure in a randomized multicenter study. 2013 Am. J. Transplant. pmid:23167508
Augusto JF et al. Long-term maintenance immunosuppressive regimen with tacrolimus monotherapy. 2013 Ann. Transplant. pmid:23872516
Rojas LE et al. Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation. 2013 Pharmacogenet. Genomics pmid:23873120
Jones AC et al. Phage p1-derived artificial chromosomes facilitate heterologous expression of the FK506 gene cluster. 2013 PLoS ONE pmid:23874942
Piram M et al. Short- and long-term outcome of linear morphoea in children. 2013 Br. J. Dermatol. pmid:24032480
Vannaprasaht S et al. Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation. 2013 Clin Ther pmid:24120259
Zlotkowski K et al. Small-molecule mechanism of action studies in Caenorhabditis elegans. 2013 Chembiochem pmid:24123757
Sapoznikov D et al. Heart rate response to blood pressure variations: sympathetic activation versus baroreflex response in patients with end-stage renal disease. 2013 PLoS ONE pmid:24124623
Hodge G et al. Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28null T cells in bronchiolitis obliterans syndrome. 2013 Clin. Exp. Immunol. pmid:23607447
Rodríguez-Perálvarez M et al. Early tacrolimus exposure after liver transplantation: relationship with moderate/severe acute rejection and long-term outcome. 2013 J. Hepatol. pmid:23023010
Tadano T et al. [A case of calcineurin-inhibitor induced pain syndrome associated with tacrolimus therapy for ulcerative colitis]. 2013 Nihon Shokakibyo Gakkai Zasshi pmid:24097149
Ben Fredj N et al. Tacrolimus therapeutic drug monitoring in Tunisian renal transplant recipients: effect of post-transplantation period. 2013 Transpl. Immunol. pmid:23608723
Yin ZQ et al. Effects of topical tacrolimus 0.03% on long-term suberythemal ultraviolet B-irradiated epidermal Langerhans cells in mice. 2013 J Eur Acad Dermatol Venereol pmid:22471949
De Bruyne R et al. Post-transplant food allergy in children is associated with liver and not with renal transplantation: a monocentric comparative study. 2013 Eur. J. Pediatr. pmid:23609525
Ciftci HS et al. Effect of MDR1 polymorphisms on the blood concentrations of tacrolimus in Turkish renal transplant patients. 2013 Transplant. Proc. pmid:23622581
Cotovio P et al. New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes. 2013 Transplant. Proc. pmid:23622631
Valente G et al. Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients: effectiveness in a real-world setting. 2013 Transplant. Proc. pmid:23622676
Gorgan M et al. Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient. 2013 Arch. Pathol. Lab. Med. pmid:24168511
Elens L et al. Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimus. 2013 Pharmacogenet. Genomics pmid:24113216
Sinha R and Marks SD Tacrolimus toxicity secondary to diarrhoea in nephrotic syndrome. 2013 Acta Paediatr. pmid:23573873
Magalhaes OA et al. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study. 2013 Br J Ophthalmol pmid:24008822
Hung TC et al. Investigation of SSEA-4 binding protein in breast cancer cells. 2013 J. Am. Chem. Soc. pmid:23574147
Quaglia M et al. Severe acute nephrotoxicity in a kidney transplant patient despite low tacrolimus levels: a possible interaction between donor and recipient genetic polymorphisms. 2013 J Clin Pharm Ther pmid:23574377
Trotter JF et al. Early use of renal-sparing agents in liver transplantation: a closer look. 2013 Liver Transpl. pmid:23696464
Wang R et al. Systemic lupus erythematosus associated with Moyamoya syndrome: a case report and literature review. 2013 Lupus pmid:23574743
Karapetyan YE et al. Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents. 2013 Proc. Natl. Acad. Sci. U.S.A. pmid:23576755
Miyoshi J et al. Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients. 2013 J Crohns Colitis pmid:23680174
Selden NR et al. Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis. 2013 J Neurosurg Pediatr pmid:23581634
Xia M et al. Enhanced FK506 production in Streptomyces tsukubaensis by rational feeding strategies based on comparative metabolic profiling analysis. 2013 Biotechnol. Bioeng. pmid:23682004
Hill JA et al. Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations. 2013 PLoS Genet. pmid:23593013
Koop DR et al. Analysis of tacrolimus and creatinine from a single dried blood spot using liquid chromatography tandem mass spectrometry. 2013 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:23548676
Lewis RE et al. Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis. 2013 J. Infect. Dis. pmid:23242544
Vafadari R et al. Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimus. 2013 Ther Drug Monit pmid:23743668
Israni AK et al. Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics. 2013 Transpl. Int. pmid:23879408
Pople PV and Singh KK Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, Part II--in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis. 2013 Eur J Pharm Biopharm pmid:23246619
Sevc J et al. Effective long-term immunosuppression in rats by subcutaneously implanted sustained-release tacrolimus pellet: effect on spinally grafted human neural precursor survival. 2013 Exp. Neurol. pmid:23748136
Cristelli MP et al. Safety profile comparing azathioprine and mycophenolate in kidney transplant recipients receiving tacrolimus and corticosteroids. 2013 Transpl Infect Dis pmid:23701592
Siegfried EC et al. Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. 2013 Am J Clin Dermatol pmid:23703374
Huang D et al. Genome-scale metabolic network guided engineering of Streptomyces tsukubaensis for FK506 production improvement. 2013 Microb. Cell Fact. pmid:23705993
Murase S Signal transducer and activator of transcription 3 (STAT3) degradation by proteasome controls a developmental switch in neurotrophin dependence. 2013 J. Biol. Chem. pmid:23733189
Min SI et al. Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy. 2013 Am. J. Transplant. pmid:23734831
Valdivieso N et al. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology. 2013 Int J Clin Pharmacol Ther pmid:23735178
Egli A et al. Comparison of the effect of standard and novel immunosuppressive drugs on CMV-specific T-cell cytokine profiling. 2013 Transplantation pmid:23274966
Zhou X et al. A genome-wide screening of potential target genes to enhance the antifungal activity of micafungin in Schizosaccharomyces pombe. 2013 PLoS ONE pmid:23738021
Hebert MF et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. 2013 Transplantation pmid:23274970
Chitnis SD et al. Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. 2013 Xenobiotica pmid:23278282
Bunnapradist S et al. Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. 2013 Am. J. Transplant. pmid:23279614
Ceschi A et al. Acute calcineurin inhibitor overdose: analysis of cases reported to a national poison center between 1995 and 2011. 2013 Am. J. Transplant. pmid:23279718
Böer TM et al. Correlation of thermal analysis and pyrolysis coupled to GC-MS in the characterization of tacrolimus. 2013 J Pharm Biomed Anal pmid:22361660
Bootun R Effects of immunosuppressive therapy on wound healing. 2013 Int Wound J pmid:22364410
Quigley MA et al. Development of a reliable model of total abdominal wall transplantation. 2013 Plast. Reconstr. Surg. pmid:24076687
Martínez-Castro M et al. Taxonomy and chemically semi-defined media for the analysis of the tacrolimus producer 'Streptomyces tsukubaensis'. 2013 Appl. Microbiol. Biotechnol. pmid:22990582
Sharma P and Barman P Everolimus for liver transplant recipients: is it ready for prime time? 2013 Gastroenterology pmid:23260492
Nara M et al. Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants. 2013 Eur. J. Clin. Pharmacol. pmid:23354810
Sofue T et al. Excess fluid distribution affects tacrolimus absorption in peritoneal dialysis patients. 2013 Clin. Exp. Nephrol. pmid:23269423
Inoue T et al. The efficacy of oral tacrolimus in patients with moderate/severe ulcerative colitis not receiving concomitant corticosteroid therapy. 2013 Intern. Med. pmid:23291669
Tanaka Y et al. [Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan]. 2013 Yakugaku Zasshi pmid:23328499
Wong R and Lin AN Efficacy of topical calcineurin inhibitors in vitiligo. 2013 Int. J. Dermatol. pmid:23331250
Loar RW et al. Posterior reversible encephalopathy syndrome and hemorrhage associated with tacrolimus in a pediatric heart transplantation recipient. 2013 Pediatr Transplant pmid:23331314
Mori T et al. Effective treatment of a 13-year-old boy with steroid-dependent ocular myasthenia gravis using tacrolimus. 2013 Brain Dev. pmid:22840813
Barbas AS et al. Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation. 2013 Am. J. Transplant. pmid:23331705